Eli Lilly agrees to up to $2.75 billion deal with Insilico Medicine for AI-developed drugs
The Facts
- Eli Lilly and Insilico Medicine announced a deal that could be worth up to $2.75 billion.
- Insilico is set to receive $115 million upfront under the agreement.
- The remaining value of the deal is tied to development, regulatory and commercial milestones, along with royalties on future sales.
- Lilly will receive exclusive worldwide rights to develop, manufacture and commercialize certain oral drug candidates that are still in preclinical development.
- The agreement expands an existing collaboration between the two companies on AI-powered drug discovery.
- The companies said they will also work together on multiple research-and-development programs focused on targets selected by Lilly.
- Insilico said it has developed at least 28 drugs using generative AI tools, with roughly half already at a clinical stage.
Context
What exactly did Lilly get in the deal?
Lilly received exclusive worldwide rights to develop, manufacture and commercialize certain preclinical oral treatments discovered by Insilico, and the companies also said they will collaborate on additional R&D programs Reuters,Morningstar,Markets Insider.
How is the $2.75 billion deal structured?
The agreement includes a $115 million upfront payment to Insilico, with the rest dependent on development, regulatory and commercial milestones, plus tiered royalties on future sales CNBC,Reuters,Bloomberg Business.
Why does this deal matter?
It shows a major drugmaker deepening its use of AI in drug discovery and adds to a growing number of partnerships aimed at speeding the path from early research to market CNBC,Reuters,Business Standard.
The receipts — all 59 sources
Wire services (5)
ReutersSuperhits 97.9 Terre Haute, INInsilico Medicine secures $2.75 billion drug collaboration w...
APBoersen-Zeitung der WM Gruppe Herausgebergemeinschaft Wertpapier-Mitteilungen, Keppler, Lehmann GmbH & Co. KG (WM Gruppe)Eli Lilly sichert sich Rechte an KI-entwickelten Medikamente...
Independent coverage (50)
Euronews EnglishEli Lilly bets on AI-powered drugs in new deal with Insilico...
Euronews DeutschEli Lilly setzt bei Insilico-Deal auf KI-gestützte Medikamen...
InvestmentNewsEli Lilly strikes up to $2.75bn deal with Insilico to accele...
东方财富网英矽智能与礼来达成对外授权与全球研发合作 交易总值最高达27.5亿美元
The News InternationalEli Lilly expands $2.75B AI-enabled drug discovery deal with...
wallstreet:onlineEli Lilly greift nach der nächsten Pharma-Revolution
ai.zhiding.cn礼来向英矽智能投资27.5亿美元建立合作伙伴关系
NewsBytesMounjaro-maker inks $2.7B deal to speed up AI drug discovery
finanzen.chKI-Offensive bei Eli Lilly: Was der Insilico-Deal für die No...
finanzen.atEli Lilly forciert KI-Strategie: Setzt der Milliarden-Deal m...
La LibertéPharma. Eli Lilly signe un accord avec une biotech cotée à H...
Le Figaro.frEli Lilly signe un accord à 2,75 milliards de dollars avec u...
EconoTimesEli Lilly and Insilico Medicine Forge $2.75 Billion AI-Drive...
Der AktionärEli Lilly: Milliardenschwerer KI-Deal - die Details
Morning BrewEli Lilly goes big on AI-generated drug discovery
Investing.com FranceEli Lilly signe un accord de 2,75 milliards de dollars avec ...
Investing.com FranceEli Lilly exige des prix plus élevés pour reprendre ses inve...
中時新聞網《半導體》AI訂單貢獻逐步俏 矽格翻紅穩高檔
英国金融时报中文版礼来与香港英矽智能达成20亿美元AI药物研发合作 - FT中文网
BW BusinessworldInsilico Medicine Signs Up To $2.75 Bn AI Drug Discovery Dea...
新浪财经礼来押注，最高约190亿元！百亿AI制药龙头重磅官宣
MorningstarEli Lilly, InSilico Strike AI Drug Discovery Deal That Could...
东方财富网创新药概念反复活跃 美诺华7天...
South China Morning PostInsilico Medicine signs AI drug development deal with Eli Li...
BoursoramaEli Lilly étend son partenariat avec Insilico Medicine pour ...
The Manila timesInsilico Medicine Announces Global R&D Collaboration with Li...
Markets InsiderInsilico announces global R&D collaboration with Eli Lilly w...
Barchart.comInsilico Medicine Announces Global R&D Collaboration with Li...
Livingston County NewsInsilico Medicine Announces Global R&D Collaboration with Li...
semafor.comEli Lilly leans into AI drug discovery with new licensing de...
Democratic UndergroundEli Lilly reaches $2.75 billion deal with Insilico to bring ...
Benzinga FranceEli Lilly conclut un accord de 2,75 milliards de dollars ave...
mintUS pharma giant Eli Lilly, Insilico Medicine secure deal wor...
STATAI drug developer Insilico Medicine and Lilly ink commercial...
news.bloomberglaw.comLilly, Insilico Ink Deal on AI Drugs Worth Up to $2.75 Billi...
Internewscast JournalEli Lilly Secures Agreement to Launch AI-Driven Medications ...
THE DECODEREli Lilly signs $2.75 billion deal with AI drug developer In...
NDTV ProfitLilly, Insilico Ink Deal On AI Drugs Worth Up To $2.75 Billi...
cnBeta.COM礼来斥资27.5亿美元与英矽智能达成合作 推广AI新药研发 - cnBeta.COM 移动版
Business StandardInsilico Medicine secures $2.75 billion drug collaboration w...
IT News zu den Themen Künstliche Intelligenz, Roboter und Maschinelles Lernen - IT BOLTWISE® x Artificial IntelligenceEli Lilly und Insilico Medicine: KI-gestützte Medikamentene...
k.sina.com.cn重磅！最高27.5亿美元！英矽智能×礼来达成AI制药重磅合作
新浪财经礼来与英矽智能达成27.5亿美元合作，企图将AI研发药物推向全球市场
IT News zu den Themen Künstliche Intelligenz, Roboter und Maschinelles Lernen - IT BOLTWISE® x Artificial IntelligenceEli Lilly investiert in KI-gestützte Arzneimittelforschung
CNBCEli Lilly reaches $2.75 billion deal with Insilico to bring ...
东方财富网英矽智能与礼来达成AI药物研发合作，交易总值最高可达27.5亿美元
新浪财经英矽智能(03696)与礼来达成一项全球管线授权与AI药物研发合作
新浪财经英矽智能与礼来达成AI药物研发合作 交易总值最高27.5亿美元
Bloomberg BusinessLilly, Insilico Ink Deal on AI Drugs Worth Up to $2.75 Billi...
东方财富网英矽智能发布2025年财报：现金储备3.93亿美元 新签署商业合作总额逾13亿美元
Facts first. Then every angle.
The day’s biggest stories in one short brief — the facts everyone agrees on, then the competing values behind the headlines. Free in your inbox.